# Spero Therapeutics, Inc.: Form SC 13D, filed Mar 14, 2018

- Company: [Spero Therapeutics, Inc.](/companies/spro.md) (CIK 1701108)
- Form: SC 13D
- Filed: 2018-03-14
- Accepted by EDGAR: Mar 14, 2018, 16:30 ET
- Period: not reported
- Accession: 0001144204-18-014661
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1701108/000114420418014661/tv488511_sc13d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1701108/000114420418014661/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1701108/000114420418014661/tv488511_sc13d.htm

Filed Mar 14, 2018.
Source: SEC EDGAR, the filing index for accession 0001144204-18-014661. Last ingested by Listed: Nov 13, 2026, 16:27 ET. No prices; not investment advice.
